section name header

Pronunciation

kee-toe-KOE-na-zole

Classifications

Therapeutic Classification: antifungals (systemic)

Indications

REMS


Action

  • Disrupts fungal cell membrane.
  • Interferes with fungal metabolism.
  • Also inhibits the production of adrenal steroids.
Therapeutic effects:
  • Fungistatic or fungicidal action against susceptible organisms, depending on organism and site of infection.

Spectrum:

Pharmacokinetics

Absorption: Absorption from the GI tract is pH dependent; increasing pH decreases absorption.

Distribution: Widely distributed. CNS penetration is unpredictable and minimal. Crosses the placenta; enters breast milk.

Protein Binding: 99%.

Metabolism/Excretion: Partially metabolized by the liver. Excreted in feces via biliary excretion.

Half-Life: 8 hr.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POrapid1–4 hr24 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: QT interval prolongation, TORSADES DE POINTES

Derm: rash, urticaria

EENT: photophobia

Endo: adrenal insufficiency, gynecomastia

GI: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, HEPATOTOXICITY

GU: male libido, azoospermia, menstrual irregularities, oligospermia

Neuro: dizziness, drowsiness

Misc: ANAPHYLAXIS

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Nizoral